Orbis Medicines
Orbis Medicines is seeking a hands‑on Research Associate to join its Platform Chemistry team in Copenhagen. The role focuses on executing automated peptide synthesis workflows, generating macrocyclic peptide libraries, and applying purification and analytical techniques on the company’s nGen platform, while collaborating with multidisciplinary scientists to deliver high‑quality compounds for drug discovery.
Orbis Medicines is a biopharmaceutical company focused on oral macrocycle drug discovery, developing next-generation small molecule drugs called nCycles that can target diseases traditionally treated with injectable biologic therapies. The company's proprietary nGen platform uses high-throughput chemistry, DNA-encoded libraries, and AI-driven deep learning to systematically explore macrocycle chemical space and identify orally bioavailable drug candidates. Orbis Medicines aims to provide oral alternatives to blockbuster biologic drugs, enabling treatment of a broader patient population across multiple therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Orbis Medicines.
Orbis Medicines didn’t post a salary, so this is our estimate from similar listings.
17% above the average for this role
Research Associate I or II - Peptide Chemistry
City of Winnipeg
Research or Senior Scientist - Peptide Chemistry
City of Pierre, South Dakota
Scientist – Peptide Chemistry
AstraZeneca
Principal Research Scientist I, Peptide Chemistry
AbbVie
Chemical Researcher - Peptide Synthesis
TAPI
Scientist I
Arrowhead Pharmaceuticals